{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:21:34Z","timestamp":1793038894800,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303855"],"award-info":[{"award-number":["82303855"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272990"],"award-info":[{"award-number":["82272990"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515011477"],"award-info":[{"award-number":["2022A1515011477"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NSFC-RGC Joint Research Scheme","award":["N_CUHK448\/23"],"award-info":[{"award-number":["N_CUHK448\/23"]}]},{"name":"CUHK direct research grant","award":["2024.066"],"award-info":[{"award-number":["2024.066"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Serine\/threonine kinase 3 (STK3) is recognized as a key regulator in Hippo pathway and a tumor-suppressing gene in various cancer types. However, its non-canonical role has been gradually revealed in cancer development.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Our objective is to elucidate the upregulation pattern and molecular mechanisms of STK3 in advancing gastric cancer (GC) progression. The regulation of YAP1 on STK3 was assessed through a combination of bulk and single-cell RNA-sequencing, Western blot, ChIP-qPCR, gene knockout mouse models, and functional rescue assays. The oncogenic roles of STK3 were confirmed through subcutaneous xenograft formation models and functional assays including spheroid formation and organoid growth. The phosphorylated target of STK3 was revealed by co-immunoprecipitation and <jats:italic>in vitro<\/jats:italic> kinase assays. STK3-targeted drugs were screened out by molecular docking and cellular thermal shift assay (CETSA).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Reduction of YAP1 significantly impaired STK3 expression at both mRNA and protein levels, and deletion of STK3 partially attenuated the oncogenic activity of YAP1. Notably, MNNG-induced tumors in <jats:italic>Yap1<\/jats:italic>\n              <jats:sup>\n                <jats:italic>\u2212\/\u2212<\/jats:italic>\n              <\/jats:sup>\n              <jats:italic>Taz<\/jats:italic>\n              <jats:sup>\n                <jats:italic>\u2212\/\u2212<\/jats:italic>\n              <\/jats:sup> mice exhibited decreased STK3 expression. Knockdown of STK3 led to reduced expression of stemness markers and xenograft growth, while sensitizing GC organoids and xenografts to 5-fluorouracil treatment. Mechanistically, the direct interaction between STK3 and GSK-3\u03b2 promoted GSK-3\u03b2 phosphorylation and \u03b2-catenin nuclear accumulation, and thus the activation of Wnt signaling. Furthermore, aminopterin demonstrates as a promising STK3-targeted small molecule with remarkable effectiveness in inhibiting GC cell malignance and xenograft growth.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>STK3 was identified as a transcriptional target of YAP1, leading to enhanced DNA repair ability and stemness acquisition during GC progression by activating Wnt\/\u03b2-catenin activity through GSK-3\u03b2 degradation. Moreover, STK3-targeted therapy offered a novel approach to concur acquired chemo-resistance in GC patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1186\/s12943-025-02391-x","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T10:08:05Z","timestamp":1751450885000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["STK3 is a transcriptional target of YAP1 and a hub component in the crosstalk between Hippo and Wnt signaling pathways during gastric carcinogenesis"],"prefix":"10.1186","volume":"24","author":[{"given":"Fuda","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoi Wing","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiejun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canbin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin H.K.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dazhi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaocai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangmin","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kam Tong","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching Hei","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigette BY","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Chun","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William KK","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Fai","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"2391_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"2391_CR2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396:635\u201348.","journal-title":"Lancet"},{"key":"2391_CR3","doi-asserted-by":"publisher","first-page":"188615","DOI":"10.1016\/j.bbcan.2021.188615","volume":"1876","author":"K Li","year":"2021","unstructured":"Li K, Zhang A, Li X, Zhang H, Zhao L. Advances in clinical immunotherapy for gastric cancer. Biochim Biophys Acta Rev Cancer. 2021;1876:188615.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2391_CR4","doi-asserted-by":"publisher","first-page":"116310","DOI":"10.1016\/j.biopha.2024.116310","volume":"173","author":"J Liu","year":"2024","unstructured":"Liu J, Yuan Q, Guo H, Guan H, Hong Z, Shang D. Deciphering drug resistance in gastric cancer: potential mechanisms and future perspectives. Biomed Pharmacother. 2024;173:116310.","journal-title":"Biomed Pharmacother"},{"key":"2391_CR5","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.devcel.2019.06.003","volume":"50","author":"Y Zheng","year":"2019","unstructured":"Zheng Y, Pan D. The Hippo signaling pathway in development and disease. Dev Cell. 2019;50:264\u201382.","journal-title":"Dev Cell"},{"key":"2391_CR6","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/s41573-020-0070-z","volume":"19","author":"A Dey","year":"2020","unstructured":"Dey A, Varelas X, Guan KL. Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine. Nat Rev Drug Discov. 2020;19:480\u201394.","journal-title":"Nat Rev Drug Discov"},{"key":"2391_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1136\/gutjnl-2019-319748","volume":"70","author":"JA Ajani","year":"2021","unstructured":"Ajani JA, Xu Y, Huo L, Wang R, Li Y, Wang Y, Pizzi MP, Scott A, Harada K, Ma L, et al. YAP1 mediates gastric adenocarcinoma peritoneal metastases that are attenuated by YAP1 Inhibition. Gut. 2021;70:55\u201366.","journal-title":"Gut"},{"key":"2391_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41419-023-05568-8","volume":"14","author":"B Messina","year":"2023","unstructured":"Messina B, Lo Sardo F, Scalera S, Memeo L, Colarossi C, Mare M, Blandino G, Ciliberto G, Maugeri-Sacc\u00e0 M, Bon G. Hippo pathway dysregulation in gastric cancer: from Helicobacter pylori infection to tumor promotion and progression. Cell Death Dis. 2023;14:21.","journal-title":"Cell Death Dis"},{"key":"2391_CR9","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1158\/1078-0432.CCR-10-2467","volume":"17","author":"W Kang","year":"2011","unstructured":"Kang W, Tong JH, Chan AW, Lee TL, Lung RW, Leung PP, So KK, Wu K, Fan D, Yu J, et al. Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis. Clin Cancer Res. 2011;17:2130\u20139.","journal-title":"Clin Cancer Res"},{"key":"2391_CR10","doi-asserted-by":"publisher","first-page":"e1481","DOI":"10.1002\/ctm2.1481","volume":"13","author":"B Chen","year":"2023","unstructured":"Chen B, Liu X, Yu P, Xie F, Kwan JSH, Chan WN, Fang C, Zhang J, Cheung AHK, Chow C, et al. H. pylori-induced NF-\u03baB-PIEZO1-YAP1-CTGF axis drives gastric cancer progression and cancer-associated fibroblast-mediated tumour microenvironment remodelling. Clin Transl Med. 2023;13:e1481.","journal-title":"Clin Transl Med"},{"key":"2391_CR11","doi-asserted-by":"crossref","unstructured":"Liu X, Chen B, Xie F, Wong KY, Cheung AH, Zhang J, Wu Q, Fang C, Hu J, Wang S et al. FOXP4 is a direct YAP1 target that promotes gastric Cancer stemness and drives metastasis. Cancer Res 2024.","DOI":"10.1158\/0008-5472.c.7523013"},{"key":"2391_CR12","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim D, Paggi JM, Park C, Bennett C, Salzberg SL. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol. 2019;37:907\u201315.","journal-title":"Nat Biotechnol"},{"key":"2391_CR13","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R. The sequence alignment\/map format and samtools. Bioinformatics. 2009;25:2078\u20139.","journal-title":"Bioinformatics"},{"key":"2391_CR14","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W. FeatureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923\u201330.","journal-title":"Bioinformatics"},{"key":"2391_CR15","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated Estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"2391_CR16","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, Feng T, Zhou L, Tang W, Zhan L, et al. ClusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov (Camb). 2021;2:100141.","journal-title":"Innov (Camb)"},{"key":"2391_CR17","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"Comprehensive molecular","year":"2014","unstructured":"Comprehensive molecular. Characterization of gastric adenocarcinoma. Nature. 2014;513:202\u20139.","journal-title":"Nature"},{"key":"2391_CR18","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nm.3850","volume":"21","author":"R Cristescu","year":"2015","unstructured":"Cristescu R, Lee J, Nebozhyn M, Kim KM, Ting JC, Wong SS, Liu J, Yue YG, Wang J, Yu K, et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med. 2015;21:449\u201356.","journal-title":"Nat Med"},{"key":"2391_CR19","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","volume":"569","author":"M Ghandi","year":"2019","unstructured":"Ghandi M, Huang FW, Jan\u00e9-Valbuena J, Kryukov GV, Lo CC, McDonald ER 3rd, Barretina J, Gelfand ET, Bielski CM, Li H, et al. Next-generation characterization of the Cancer cell line encyclopedia. Nature. 2019;569:503\u20138.","journal-title":"Nature"},{"key":"2391_CR20","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1093\/bioinformatics\/bty411","volume":"34","author":"CJ Liu","year":"2018","unstructured":"Liu CJ, Hu FF, Xia MX, Han L, Zhang Q, Guo AY. GSCALite: a web server for gene set cancer analysis. Bioinformatics. 2018;34:3771\u20132.","journal-title":"Bioinformatics"},{"key":"2391_CR21","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1093\/carcin\/bgt409","volume":"35","author":"B Lim","year":"2014","unstructured":"Lim B, Park JL, Kim HJ, Park YK, Kim JH, Sohn HA, Noh SM, Song KS, Kim WH, Kim YS, Kim SY. Integrative genomics analysis reveals the multilevel dysregulation and oncogenic characteristics of TEAD4 in gastric cancer. Carcinogenesis. 2014;35:1020\u20137.","journal-title":"Carcinogenesis"},{"key":"2391_CR22","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1158\/1078-0432.CCR-19-3231","volume":"26","author":"A Sathe","year":"2020","unstructured":"Sathe A, Grimes SM, Lau BT, Chen J, Suarez C, Huang RJ, Poultsides G, Ji HP. Single-Cell genomic characterization reveals the cellular reprogramming of the gastric tumor microenvironment. Clin Cancer Res. 2020;26:2640\u201353.","journal-title":"Clin Cancer Res"},{"key":"2391_CR23","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol. 2018;36:411\u201320.","journal-title":"Nat Biotechnol"},{"key":"2391_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"key":"2391_CR25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1126\/science.aax0249","volume":"367","author":"GS Gulati","year":"2020","unstructured":"Gulati GS, Sikandar SS, Wesche DJ, Manjunath A, Bharadwaj A, Berger MJ, Ilagan F, Kuo AH, Hsieh RW, Cai S, et al. Single-cell transcriptional diversity is a hallmark of developmental potential. Science. 2020;367:405\u201311.","journal-title":"Science"},{"key":"2391_CR26","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell C, Cacchiarelli D, Grimsby J, Pokharel P, Li S, Morse M, Lennon NJ, Livak KJ, Mikkelsen TS, Rinn JL. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol. 2014;32:381\u20136.","journal-title":"Nat Biotechnol"},{"key":"2391_CR27","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ. AutoDock4 and AutoDockTools4: automated Docking with selective receptor flexibility. J Comput Chem. 2009;30:2785\u201391.","journal-title":"J Comput Chem"},{"key":"2391_CR28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ccell.2020.05.019","volume":"38","author":"Y Tang","year":"2020","unstructured":"Tang Y, Fang G, Guo F, Zhang H, Chen X, An L, Chen M, Zhou L, Wang W, Ye T, et al. Selective Inhibition of STRN3-Containing PP2A phosphatase restores Hippo Tumor-Suppressor activity in gastric Cancer. Cancer Cell. 2020;38:115\u2013e128119.","journal-title":"Cancer Cell"},{"key":"2391_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41392-020-0110-5","volume":"5","author":"L Yang","year":"2020","unstructured":"Yang L, Shi P, Zhao G, Xu J, Peng W, Zhang J, Zhang G, Wang X, Dong Z, Chen F, Cui H. Targeting cancer stem cell pathways for cancer therapy. Signal Transduct Target Ther. 2020;5:8.","journal-title":"Signal Transduct Target Ther"},{"key":"2391_CR30","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41580-022-00571-x","volume":"24","author":"SW Awwad","year":"2023","unstructured":"Awwad SW, Serrano-Benitez A, Thomas JC, Gupta V, Jackson SP. Revolutionizing DNA repair research and cancer therapy with CRISPR-Cas screens. Nat Rev Mol Cell Biol. 2023;24:477\u201394.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2391_CR31","doi-asserted-by":"crossref","unstructured":"Shin WS, Xie F, Chen B, Yu P, Yu J, To KF, Kang W. Updated epidemiology of gastric Cancer in asia: decreased incidence but still a big challenge. Cancers (Basel) 2023, 15.","DOI":"10.3390\/cancers15092639"},{"key":"2391_CR32","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s13046-023-02870-3","volume":"42","author":"T Wang","year":"2023","unstructured":"Wang T, Wang D, Sun Y, Zhuang T, Li X, Yang H, Zang Y, Liu Z, Yang P, Zhang C, et al. Regulation of the hippo\/yap axis by CXCR7 in the tumorigenesis of gastric cancer. J Exp Clin Cancer Res. 2023;42:297.","journal-title":"J Exp Clin Cancer Res"},{"key":"2391_CR33","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1136\/gutjnl-2023-329686","volume":"73","author":"F Zhang","year":"2024","unstructured":"Zhang F, Sahu V, Peng K, Wang Y, Li T, Bala P, Aitymbayev D, Sahgal P, Schaefer A, Der CJ, et al. Recurrent RhoGAP gene fusion CLDN18-ARHGAP26 promotes RHOA activation and focal adhesion kinase and YAP-TEAD signalling in diffuse gastric cancer. Gut. 2024;73:1280\u201391.","journal-title":"Gut"},{"key":"2391_CR34","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41586-019-1426-6","volume":"572","author":"J Wu","year":"2019","unstructured":"Wu J, Minikes AM, Gao M, Bian H, Li Y, Stockwell BR, Chen ZN, Jiang X. Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling. Nature. 2019;572:402\u20136.","journal-title":"Nature"},{"key":"2391_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12964-023-01396-7","volume":"22","author":"KM Choi","year":"2024","unstructured":"Choi KM, Kim B, Lee SM, Han J, Bae HS, Han SB, Lee D, Ham IH, Hur H, Kim E, Kim JY. Characterization of gastric cancer-stimulated signaling pathways and function of CTGF in cancer-associated fibroblasts. Cell Commun Signal. 2024;22:8.","journal-title":"Cell Commun Signal"},{"key":"2391_CR36","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s13046-022-02463-6","volume":"41","author":"Y Li","year":"2022","unstructured":"Li Y, Fan Y, Xu J, Huo L, Scott AW, Jin J, Yang B, Shao S, Ma L, Wang Y, et al. GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma. J Exp Clin Cancer Res. 2022;41:257.","journal-title":"J Exp Clin Cancer Res"},{"key":"2391_CR37","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1101\/gad.1664408","volume":"22","author":"B Zhao","year":"2008","unstructured":"Zhao B, Ye X, Yu J, Li L, Li W, Li S, Yu J, Lin JD, Wang CY, Chinnaiyan AM, et al. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 2008;22:1962\u201371.","journal-title":"Genes Dev"},{"key":"2391_CR38","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ydbio.2020.12.018","volume":"475","author":"F Szulzewsky","year":"2021","unstructured":"Szulzewsky F, Holland EC, Vasioukhin V. YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance. Dev Biol. 2021;475:205\u201321.","journal-title":"Dev Biol"},{"key":"2391_CR39","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ymthe.2021.08.029","volume":"30","author":"AU Schirmer","year":"2022","unstructured":"Schirmer AU, Driver LM, Zhao MT, Wells CI, Pickett JE, O\u2019Bryne SN, Eduful BJ, Yang X, Howard L, You S, et al. Non-canonical role of Hippo tumor suppressor serine\/threonine kinase 3 STK3 in prostate cancer. Mol Ther. 2022;30:485\u2013500.","journal-title":"Mol Ther"},{"key":"2391_CR40","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10549-024-07248-3","volume":"206","author":"AT Rukhsana, Supty","year":"2024","unstructured":"Rukhsana, Supty AT, Hussain M, Lee Y. STK3 higher expression association with clinical characteristics in intrinsic subtypes of breast cancer invasive ductal carcinoma patients. Breast Cancer Res Treat. 2024;206:119\u201329.","journal-title":"Breast Cancer Res Treat"},{"key":"2391_CR41","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12943-021-01451-2","volume":"20","author":"B Chen","year":"2021","unstructured":"Chen B, Chan WN, Mui CW, Liu X, Zhang J, Wang Y, Cheung AHK, Chan AKY, Chan RCK, Leung KT, et al. STK3 promotes gastric carcinogenesis by activating Ras-MAPK mediated cell cycle progression and serves as an independent prognostic biomarker. Mol Cancer. 2021;20:147.","journal-title":"Mol Cancer"},{"key":"2391_CR42","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/cac2.12138","volume":"41","author":"G Pan","year":"2021","unstructured":"Pan G, Liu Y, Shang L, Zhou F, Yang S. EMT-associated MicroRNAs and their roles in cancer stemness and drug resistance. Cancer Commun (Lond). 2021;41:199\u2013217.","journal-title":"Cancer Commun (Lond)"},{"key":"2391_CR43","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1053\/j.gastro.2023.01.037","volume":"164","author":"Q Chen","year":"2023","unstructured":"Chen Q, Weng K, Lin M, Jiang M, Fang Y, Chung SSW, Huang X, Zhong Q, Liu Z, Huang Z, et al. SOX9 modulates the transformation of gastric stem cells through biased symmetric cell division. Gastroenterology. 2023;164:1119\u2013e11361112.","journal-title":"Gastroenterology"},{"key":"2391_CR44","doi-asserted-by":"publisher","first-page":"101080","DOI":"10.1016\/j.drup.2024.101080","volume":"74","author":"G Che","year":"2024","unstructured":"Che G, Yin J, Wang W, Luo Y, Chen Y, Yu X, Wang H, Liu X, Chen Z, Wang X, et al. Circumventing drug resistance in gastric cancer: A Spatial multi-omics exploration of chemo and immuno-therapeutic response dynamics. Drug Resist Updat. 2024;74:101080.","journal-title":"Drug Resist Updat"},{"key":"2391_CR45","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12943-020-01185-7","volume":"19","author":"L Wei","year":"2020","unstructured":"Wei L, Sun J, Zhang N, Zheng Y, Wang X, Lv L, Liu J, Xu Y, Shen Y, Yang M. Noncoding RNAs in gastric cancer: implications for drug resistance. Mol Cancer. 2020;19:62.","journal-title":"Mol Cancer"},{"key":"2391_CR46","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.ccell.2016.05.005","volume":"29","author":"F Zanconato","year":"2016","unstructured":"Zanconato F, Cordenonsi M, Piccolo S. YAP\/TAZ at the roots of Cancer. Cancer Cell. 2016;29:783\u2013803.","journal-title":"Cancer Cell"},{"key":"2391_CR47","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1158\/0008-5472.CAN-22-3003","volume":"83","author":"K Wang","year":"2023","unstructured":"Wang K, Ma F, Arai S, Wang Y, Varkaris A, Poluben L, Voznesensky O, Xie F, Zhang X, Yuan X, Balk SP. WNT5a signaling through ROR2 activates the Hippo pathway to suppress YAP1 activity and tumor growth. Cancer Res. 2023;83:1016\u201330.","journal-title":"Cancer Res"},{"key":"2391_CR48","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1053\/j.gastro.2023.01.041","volume":"164","author":"J Wang","year":"2023","unstructured":"Wang J, Yu H, Dong W, Zhang C, Hu M, Ma W, Jiang X, Li H, Yang P, Xiang D. N6-Methyladenosine-Mediated Up-Regulation of FZD10 regulates liver Cancer stem cells\u2019 properties and lenvatinib resistance through WNT\/\u03b2-Catenin and Hippo signaling pathways. Gastroenterology. 2023;164:990\u20131005.","journal-title":"Gastroenterology"},{"key":"2391_CR49","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1053\/j.gastro.2022.04.028","volume":"163","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Xu H, Cui G, Liang B, Chen X, Ko S, Affo S, Song X, Liao Y, Feng J, et al. \u03b2-Catenin sustains and is required for YES-associated protein oncogenic activity in cholangiocarcinoma. Gastroenterology. 2022;163:481\u201394.","journal-title":"Gastroenterology"},{"key":"2391_CR50","doi-asserted-by":"crossref","unstructured":"More CCB, Bueno AC, Rojas CAO, Stecchini MF, Ramalho FS, Brandalise SR, Cardinalli IA, Yunes JA, Junqueira T, Scrideli CA et al. YAP1 is a prognostic marker and its Inhibition reduces tumor progression in adrenocortical tumors. J Clin Endocrinol Metab 2025.","DOI":"10.1210\/clinem\/dgaf013"},{"key":"2391_CR51","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1158\/0008-5472.CAN-24-1254","volume":"85","author":"Y Cui","year":"2025","unstructured":"Cui Y, Chang Y, Ma X, Sun M, Huang Y, Yang F, Li S, Zhuo W, Liu W, Yang B, et al. Ephrin A1 stimulates CCL2 secretion to facilitate premetastatic niche formation and promote gastric Cancer liver metastasis. Cancer Res. 2025;85:263\u201376.","journal-title":"Cancer Res"},{"key":"2391_CR52","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cub.2008.02.006","volume":"18","author":"M Praskova","year":"2008","unstructured":"Praskova M, Xia F, Avruch J. MOBKL1A\/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation. Curr Biol. 2008;18:311\u201321.","journal-title":"Curr Biol"},{"key":"2391_CR53","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1083\/jcb.201507005","volume":"210","author":"BJ Thompson","year":"2015","unstructured":"Thompson BJ, Sahai E. MST kinases in development and disease. J Cell Biol. 2015;210:871\u201382.","journal-title":"J Cell Biol"},{"key":"2391_CR54","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0092-8674(01)00374-9","volume":"105","author":"R Dajani","year":"2001","unstructured":"Dajani R, Fraser E, Roe SM, Young N, Good V, Dale TC, Pearl LH. Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell. 2001;105:721\u201332.","journal-title":"Cell"},{"key":"2391_CR55","doi-asserted-by":"publisher","first-page":"352ra108","DOI":"10.1126\/scitranslmed.aaf2304","volume":"8","author":"F Fan","year":"2016","unstructured":"Fan F, He Z, Kong LL, Chen Q, Yuan Q, Zhang S, Ye J, Liu H, Sun X, Geng J, et al. Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration. Sci Transl Med. 2016;8:352ra108.","journal-title":"Sci Transl Med"},{"key":"2391_CR56","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1200\/JCO.1998.16.4.1458","volume":"16","author":"AF Ratliff","year":"1998","unstructured":"Ratliff AF, Wilson J, Hum M, Marling-Cason M, Rose K, Winick N, Kamen BA. Phase I and Pharmacokinetic trial of aminopterin in patients with refractory malignancies. J Clin Oncol. 1998;16:1458\u201364.","journal-title":"J Clin Oncol"},{"key":"2391_CR57","doi-asserted-by":"publisher","first-page":"8089","DOI":"10.1158\/1078-0432.CCR-05-0355","volume":"11","author":"PD Cole","year":"2005","unstructured":"Cole PD, Drachtman RA, Smith AK, Cate S, Larson RA, Hawkins DS, Holcenberg J, Kelly K, Kamen BA. Phase II trial of oral aminopterin for adults and children with refractory acute leukemia. Clin Cancer Res. 2005;11:8089\u201396.","journal-title":"Clin Cancer Res"},{"key":"2391_CR58","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1124\/jpet.112.195479","volume":"342","author":"A Menter","year":"2012","unstructured":"Menter A, Thrash B, Cherian C, Matherly LH, Wang L, Gangjee A, Morgan JR, Maeda DY, Schuler AD, Kahn SJ, Zebala JA. Intestinal transport of aminopterin enantiomers in dogs and humans with psoriasis is stereoselective: evidence for a mechanism involving the proton-coupled folate transporter. J Pharmacol Exp Ther. 2012;342:696\u2013708.","journal-title":"J Pharmacol Exp Ther"},{"key":"2391_CR59","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.exppara.2009.06.007","volume":"123","author":"B Irungu","year":"2009","unstructured":"Irungu B, Kiboi D, Langat B, Rukunga G, Wittlin S, Nzila A. Methotrexate and aminopterin lack in vivo antimalarial activity against murine malaria species. Exp Parasitol. 2009;123:118\u201321.","journal-title":"Exp Parasitol"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02391-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-025-02391-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02391-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T11:03:35Z","timestamp":1751454215000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-025-02391-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2391"],"URL":"https:\/\/doi.org\/10.1186\/s12943-025-02391-x","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"21 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The use of human samples was approved by the Joint Chinese University of Hong Kong-New Territories East Cluster Clinical Research Ethics Committee, Hong Kong (CREC Ref. No.: 2022-060). A waiver of consent form was granted by the Ethics Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"186"}}